Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2020

Month: October

Request Number: A-2020-000961

Request Summary: The most current Risk Management Plan (RMP) and RMP review report for Novolin (Insulin) associated with any of the following Drug Identification Numbers (DIN): 02024217, 02025248, 02024314, 02024322, 02024225, 02024233, 02024268, 02024284 by Novo Nordisk Canada Inc.

Disposition: No records exist

Number of pages: 0

Date modified: